Continuing Medical Education
Accreditation Statement
The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Credit Designation Statement
AACR has designated this internet live activity for a maximum of 33.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.
Claiming CME Credit
Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this live continuing medical education activity must complete the online CME Request for Credit Survey by Wednesday, September 2, 2020. Certificates will only be issued to those who complete the survey. The Request for Credit Survey will be available via a link on this web page and via email. Your CME certificate will be sent to you via email after the completion of the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 33.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive ABIM MOC, participants must request MOC in the CME Request for Credit Survey and complete all questions. Once these steps are completed, AACR will submit your completion information via the ACCME’s Program and Activity Reporting System for the purpose of granting MOC points.
Statement of Educational Need, Target Audience, and Learning Objectives
This will be the first major event which will focus on the effects of COVID-19 on cancer care and research and the unique position that the cancer researchers (basic, translational, epidemiological, and clinical) to influence the trajectory and long-term implications of the pandemic. The program will be presented on a virtual platform over three (3) days to allow ample opportunity for participants to view invited and proffered presentations and participate in lengthy “virtual discussions” through an integrated, online chat function.
The coronavirus outbreak that has been declared a pandemic by the World Health Organization is affecting people throughout the United States and around the world – impacting practicing oncologists, clinical investigators, translational and basic researchers, and every aspect of biomedical research and patient clinical care.
Challenges and disruptions caused by the coronavirus at doctors’ offices, hospitals, research labs, and other locations have impacted cancer treatment regimens, participation in clinical trials, and ongoing research.
This program will gather thought leaders across a range of topic areas that have practice implications for clinicians, both within oncology and across other medical specialties. The unique conference will present emerging data on continuity of care, drug repurposing, early detection and testing, and health disparities and inequities which are of vital importance to physicians and related medical professionals.
As of May 15, 2020, the World Health Organization had declared over 4.3 million confirmed cases of COVID-19 and over 295,000 deaths as a result of the virus. Although some countries have seen a leveling or decline of new cases, the worldwide trend continues to grow with over 1 million new cases since May 1.
The COVID-19 global pandemic has impacted all sectors of global society; including the biomedical research and patient care communities. This virtual meeting aims to provide an educational platform on a variety of topics including several directly related to patient care during and after the pandemic. The meeting will communicate to a diverse set of stakeholders who may not otherwise have an opportunity to interact at a live event that would have required additional costs of time, travel, housing, etc.
After participating in this CME activity, physicians should be able to:
- Identify opportunities to incorporate “digital health” strategies such as telehealth, virtual office visits, remote consenting, and home care into current and post-COVID-19 healthcare settings.
- Assess the impact of regulatory changes on drug development and clinical trial design.
- Evaluate opportunities for the repurposing of cancer therapeutics as treatment options in the COVID-19 era.
- Articulate how outcomes may be impacted by socioeconomic, ethnic, gender, and other health disparities.
Disclosure Statement
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information is available below.
Acknowledgment of Financial or Other Support
The AACR gratefully acknowledges the following commercial supporters:
SUPPORTERS
GlaxoSmithKline
Janssen
Novartis
Pharmacyclics, An AbbVie Company & Janssen Biotech
Professional Education Grants
AbbVie
Pfizer
Questions about CME?
Please contact the Office of CME at (215) 440-9300 or [email protected].